Through interviews and articles infused with expert insight, progress against this cancer that develops in the bone marrow ...
Indapta Therapeutics raises $22.5 million to advance clinical trials for IDP-023, its g-NK cell therapy platform targeting cancer and autoimmune diseases. The funding supports ongoing studies in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback